首页>
外国专利>
Identification and quantification of biomarkers for risk of preterm birth ASSESSMENT
Identification and quantification of biomarkers for risk of preterm birth ASSESSMENT
展开▼
机译:鉴定和量化早产风险的生物标志物
展开▼
页面导航
摘要
著录项
相似文献
摘要
1. A method for assessing the risk of preterm labor in a pregnant subject comprising: (a) identifying a combination of the first biomarker and second biomarker present in a biological sample from the subject, wherein the first biomarker includes the amino acid sequence of SEQ ID NO: 1, SEQ ID NO: 2 , SEQ ID NO: 3, or any combination thereof, and the second biomarker is a protein comprising kortikotrofin-releasing factor, defensin, ferritin, lactoferrin complex of thrombin - antithrombin, receptor type 1 factor α tumor necrosis or any combination thereof, and (b ) about amount-determination of the first and second biomarkers in a biological obraztse.2. A method according to claim 1, wherein step (b) comprises determining the relative content of the first and second biomarkerov.3. A method according to claim 2, further comprising: comparing the content of the first and second biomarker in a biological sample from a control concentration of said first and second control biomarkers in a biological sample originating from a subject who does not have any premature labor, for the establishment of an increased risk of preterm rodov.4. A method according to claim 3, wherein the determination of increased risk of preterm delivery include determining that the contents of at least one peptide in a biological sample is significantly less than the control concentration of at least one peptide in a control biological obraztse.5. A method according to claim 2, further comprising: comparing the content of the first and second biomarker in a biological sample from a control concentration of test molecule in a biological sample from the subject for the establishment of an increased risk of preterm p
展开▼
机译:1.一种用于评估妊娠受试者中早产风险的方法,其包括:(a)鉴定来自受试者的生物样品中存在的第一生物标志物和第二生物标志物的组合,其中第一生物标志物包括SEQ ID NO:1的氨基酸序列。 ID NO:1,SEQ ID NO:2,SEQ ID NO:3或它们的任意组合,并且第二生物标记物是一种蛋白质,其包含甲睾酮释放因子,防御素,铁蛋白,凝血酶的乳铁蛋白复合物-抗凝血酶,受体1型因子α肿瘤坏死或其任何组合,以及(b)关于生物标记中第一和第二生物标记物含量的测定; 2。 2.根据权利要求1的方法,其中步骤(b)包括确定第一和第二生物标志物3的相对含量。 3.根据权利要求2所述的方法,还包括:将生物样品中的所述第一和第二生物标志物的含量与来自没有早产的受试者的生物样品中的所述第一和第二对照生物标志物的对照浓度进行比较,用于增加早产杆状病毒的风险4。 4.根据权利要求3所述的方法,其中,确定增加早产风险的步骤包括确定生物学样品中至少一种肽的含量显着低于对照生物学过时酶中至少一种肽的对照浓度。5。 3.根据权利要求2所述的方法,其进一步包括:比较来自所述受试者的生物样品中的对照分子的测试浓度的对照样品中的生物样品中的所述第一和第二生物标志物的含量,以建立早产p风险的增加。
展开▼